Five-Years Tigecycline Experience an Analysis of Real-Life Data

Temocin F., Tulek N. E., Hekimoglu S., Ilgar T., Bulut C., Erdinc F. S., ...More

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, vol.56, no.2, pp.125-130, 2018 (ESCI, Scopus, TRDizin) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 56 Issue: 2
  • Publication Date: 2018
  • Doi Number: 10.4274/haseki.42713
  • Journal Name: HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.125-130
  • Keywords: Tigecycline, real life data, minocycline, EFFICACY, GLYCYLCYCLINE, GAR-936, TETRACYCLINE, INFECTIONS, BINDING, SAFETY, MODEL
  • Recep Tayyip Erdoğan University Affiliated: No

Abstract

Aim: Tigecycline has been approved by the Food and Drug Administration for the treatment of complicated intra-abdominal infections, skin and soft tissue infections and community-acquired pneumonia. In our study, we examined the efficacy of tigecycline in clinical practice and reported real life data from our hospital over a period of five years.